Credit Suisse Hais tias AbbVie's Humira Patent Cliff tuaj yeem muab lub zog los txhawb kev loj hlob

Credit Suisse tau pib qhov kev pab cuam ntawm AbbVie Inc (NYSE: ABBV) nrog qhov kev ntsuas ua tau zoo thiab tus nqi phiaj ntawm $ 170. AbbVie sawv ntawm ntug ntawm qhov muag zoo tshaj plaws Humira US poob ntawm kev cais tawm (LOE) ...

AbbVie's Correction Appears to Be Over: Nov Yog Qhov Tshuag Yuav Tau Tau Mus

AbbVie (ABBV), lub tuam txhab tshawb fawb-raws li biopharmaceutical tuam txhab uas tau tawm ntawm Abbott Laboratories (ABT) hauv 2013, tau ua qhov kev txav siab siab dua li cuaj xyoo dhau los. Tsis ntev los no, ABBV rub ba ...

AbbVie cov khoom lag luam nce ntawm cov nyiaj tau los hauv peb lub quarter thib plaub raws li nws tshaj tawm tias kev muag khoom zoo dua li kev cia siab ntawm Humira

Ib qho dhau los ntawm tsab ntawv ceeb toom no tau xa mus rau Humana hauv xov xwm, tsis yog Humira. Nws tau raug kho lawm. Shares ntawm AbbVie Inc. ABBV, +0.08% tau nce 1.4% hauv kev lag luam ua ntej hnub Wednesday tom qab lub comp ...